Ryder, J R
Kaizer, A
Rudser, K D
Gross, A
Kelly, A S
Fox, C K
Article History
Received: 28 June 2016
Revised: 29 August 2016
Accepted: 3 September 2016
First Online: 24 October 2016
Competing interests
: Dr Kelly serves as a consultant for Novo Nordisk Pharmaceuticals, but does not receive personal or professional income for these activities. Dr Kelly receives research support in the form of drug/placebo from Astra Zeneca Pharmaceuticals. Dr Fox serves as a site principal investigator for a clinical trial sponsored by Novo Nordisk Pharmaceuticals. The other authors declare no conflict of interest. No honorarium, grant or other form of payment was given to anyone to produce the manuscript.